The latest data & strategies impacting the development of oncolytic viruses, from discovery and biomarker development through to regulatory approval
The programme brings together international pharmaceutical organisations, leading biotech companies and globally renowned academic institutions specialising in the development of oncolytic viruses
Full details on the Symposium including the presentations, topic areas and confirmed speakers will be released in the conference brochure in the coming weeks
Full Registration is now open for Virtual Symposium: Oncolytic Viruses. Please click the button below to register for this event.
Our LinkedIn group aims to foster discussion and collaboration between experts working in immunotherapy, autoimmunity and immuno-oncology
Engineering & Translational Strategies
Accelerating Oncolytic Virus Immunotherapy To The Clinic
The Virtual Symposium brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry perspectives.
Below are featured past speakers from our Immuno Series:
Themis Bioscience GmbH
Christian Doppler Laboratory for Viral Immunotherapy of Cancer
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual, remote experiences.